| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.3M | +206.7% |
| R&D Expense | $80.3M | +39.2% |
| SG&A Expense | $21.7M | +93.2% |
| Operating Income | -$100.7M | -47.0% |
| Interest Expense | $1.9M | +94.7% |
| Net Income | -$101.3M | -47.3% |
| EPS (Basic) | -$2.73 | +56.2% |
| EPS (Diluted) | -$2.73 | +56.2% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $101.1M | +9.0% |
| Current Assets | $459.6M | +141.0% |
| Total Assets | $519.8M | +103.4% |
| Current Liabilities | $48.7M | +158.4% |
| Long-term Debt | $0 | -100.0% |
| Total Liabilities | $422.9M | +286.5% |
| Stockholders' Equity | $96.9M | -33.7% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$50.3M | -60.6% |
| Capital Expenditures | $3.3M | -79.5% |
| Investing Cash Flow | $36.2M | +133.2% |
| Financing Cash Flow | $22.4M | -89.7% |
| Free Cash Flow | -$53.6M | -12.8% |